OPINION
NEWS
REGIONS
WORLD
BUSINESS
SPORTS
ENTERTAINMENT
LIFESTYLE
THE SUNDAY TIMES
SPECIAL FEATURES
SPECIAL SECTIONS
TMT NEWSWIRE
FAST TIMES
LEGAL ADVICE
CAMPUS PRESS
VIDEOS
EXPATS & DIPLOMATS
PHOTOS
BUSINESS FORUM
PODCASTS
RESOURCES
WEATHER
MARKET OVERVIEW
CLASSIFIEDS
EXAM RESULTS
TMT DIGITAL EDITION
TMT CSI
TMT 126TH ANNIVERSARY
QUIZZES
GAMES
TMT Newswire > GlobeNewswire
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers
by GlobeNewswire
Oct 11, 2024 4:28 am

Register to unlock this article

Register to read this story and more for free.

Signing up for an account helps us improve your browsing experience.

Continue

OR

See our subscription options.

Already have an account? Log in here

Related Articles

Berry and Glatfelter Announce Pricing of Upsized Senior Secured Notes Offering by Berry Subsidiary in Connection with Proposed Merger of Berry's Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter

Upstream Bio Announces Pricing of Upsized Initial Public Offering

StateHouse Announces Canadian Parent Enters Bankruptcy Proceedings in Canada following Initiation of Receivership Proceedings in the U.S.

Monarch Casino & Resort to Report 2024 Third Quarter Results After Market Close on October 23

CZR Exchange Launches to Unlock the Future of Crypto

Disposition of Class B Shares of Lions Gate Entertainment Corp.

Tejon Ranch Company and Dedeaux Properties Announce Joint Venture to Develop Industrial Warehouse at the Tejon Ranch Commerce Center